Advancedmolecular
Homologous Recombination
Overview
Homologous recombination (HR) repairs double-strand breaks using an identical sister chromatid as template, and in meiosis it creates crossovers between homologs. The mechanism: 5'->3' resection, RAD51 filament formation, strand invasion forming a D-loop, Holliday junction migration, and resolution as crossover or non-crossover. BRCA1/2 orchestrate it; defects cause cancer predisposition.
Learning objectives
- Outline the HR mechanism step by step
- Explain Holliday junctions and resolution
- Connect HR to meiotic crossing over
- Explain BRCA's role and cancer link
The repair pathway
After a double-strand break: MRN complex resects 5' ends leaving 3' overhangs; BRCA1 promotes resection, BRCA2 loads RAD51 onto ssDNA; the filament invades the sister chromatid (D-loop); DNA synthesis extends the invading strand; Holliday junctions form, migrate, and resolve. Using the identical sister makes HR essentially error-free.
Identity of the template is what makes HR accurate; NHEJ has no template and errs.
Holliday junctions
Robin Holliday's 1964 model: the crossed-strand intermediate can migrate (branch migration) and be cut two ways, crossover or non-crossover. In mitotic repair, non-crossover (SDSA) predominates; in meiosis, programmed DSBs (Spo11) resolve as crossovers ensuring homolog disjunction.
Which strands are cut determines whether flanking markers exchange.
Meiotic recombination
Meiotic HR deliberately breaks DNA (Spo11, ~200-400 DSBs in humans) to create crossovers: at least one per homolog pair (obligate crossover) physically tethers homologs for proper segregation. Gene conversion (non-crossover) also occurs, copying short patches between homologs.
Achloriasmate homologs missegregate: the molecular basis of age-related aneuploidy.
BRCA and genome stability
BRCA1 (scaffold/signaling) and BRCA2 (RAD51 loading) are HR essentials; heterozygous mutations predispose to breast/ovarian (BRCA1/2), prostate, pancreatic cancers. Tumors losing the second allele are HR-deficient: sensitive to PARP inhibitors and platinum drugs.
BRCAness, whether inherited or somatic, predicts PARP inhibitor response.
Key points
- HR uses the sister chromatid for error-free double-strand break repair
- Holliday junctions resolve as crossover or non-crossover products
- Meiotic Spo11 DSBs create obligate crossovers for disjunction
- BRCA1/2 enable HR; their loss creates druggable HR deficiency
Common misconceptions
✓ Truth: HR's template makes it high-fidelity; NHEJ ligates ends with frequent small indels.
✓ Truth: Its mechanical role, tethering homologs for segregation, is equally essential.
Practice questions
Q1. Homologous recombination is accurate because it uses
- No template
- The identical sister chromatid as template
- Random DNA
- RNA
Template identity enables error-free repair, unlike NHEJ.
Q2. Holliday junctions are resolved into
- Only crossovers
- Crossover or non-crossover products
- Deletions only
- Telomeres
Cutting the crossed strands either way gives the two outcomes.
Q3. BRCA1/2-deficient cancers are sensitive to PARP inhibitors due to
- Immune activation
- Synthetic lethality
- Hormone dependence
- Angiogenesis
Losing both HR and PARP-mediated backup repair is lethal to the tumor.
Click a question to reveal the answer and explanation.
Frequently asked questions
What initiates meiotic recombination?
Spo11 deliberately inflicts double-strand breaks, later repaired as crossovers.
Why is BRCA2 called a RAD51 loader?
It delivers RAD51 onto resected ssDNA, nucleating the homology-search filament.
What is synthesis-dependent strand annealing?
The non-crossover HR sub-pathway: the invading strand extends then withdraws, annealing back without junction formation.